99mTc-chelator engineering to improve tumour targeting properties of a HER2-specific Affibody molecule.
| Publicado en: | European Journal of Nuclear Medicine & Molecular Imaging Vol. 34; no. 11; pp. 1843 - 1854 |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Nov2007
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104325835&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 104325835 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 16197070 NPC jtl: European Journal of Nuclear Medicine & Molecular Imaging issn: 16197070 maglogo: N pubinfo: dt: Nov2007 vid: 34 iid: 11 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 104325835 2011947091 10.1007/s00259-007-0474-6 104325835 ppf: 1843 ppct: 11 formats: fmt: @attributes: type: P tig: atl: 99mTc-chelator engineering to improve tumour targeting properties of a HER2-specific Affibody molecule. aug: au: Engfeldt, Torun Tran, Thuy Orlova, Anna Widström, Charles Feldwisch, Joachim Abrahmsen, Lars Wennborg, Anders Karlström, Amelie Tolmachev, Vladimir affil: School of Biotechnology , Royal Institute of Technology , Stockholm Sweden sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|